| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |